drugset / Trial / NCT06840496
To Investigate the Efficacy of Treatment With Oral NA-921 (Bionetide) Versus Placebo in Females With Rett Syndrome
RandomizedParallel-groupQuadruple-blindTreatment
Summary
Primary Objective • To investigate the efficacy of treatment with oral Bionetide versus placebo in girls and women with Rett syndrome Key Secondary Objective • To investigate the efficacy of treatment with oral Bionetide versus placebo on ability to communicate in girls and women with Rett syndrome
Timeline
- Start
- 2026-09-30
- Primary completion
- 2027-09-30
- Completion
- 2027-12-30
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bionetide | Unknown | 20 ml | Oral |
| Subject | Bionetide | Unknown | 40 ml | Oral |